Work

Patient out-of-pocket costs for antihypertensive single pill combination products with cost caps

Year: 2026

Type: article

Study design: Observational Study

Source: Journal of Human Hypertension

DOI: 10.1038/s41371-026-01177-y

Authors: Catherine G. Derington, Kyle Tong, Joshua A. Jacobs, Brent M. Egan, Jordan B. King, Adam P. Bress, Anthony Rodgers, Jaejin An, Kelsey B. Bryant, Jordana B. Cohen, Brandon K. Bellows

Institutions: University of Colorado Anschutz, University of Colorado Denver, Columbia University, University of Utah, American Medical Association, Intermountain Healthcare, George E. Wahlen Department of VA Medical Center, UNSW Sydney, The George Institute for Global Health, Kaiser Permanente, Icahn School of Medicine at Mount Sinai, University of Pennsylvania, Columbia University Irving Medical Center

Language: English

Topic: Blood Pressure and Hypertension Studies

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute on Aging, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: HeartShare: Next-Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets - Clinical Centers, Blockade of calcium channels and beta adrenergic receptors for physiologic abnormalities in heart failure with preserved ejection fraction (BLOCK HFpEF), Guiding next steps for SPRINT-MIND implementation: Identifying high-benefit subgroups and comparative effects of ARB- vs. ACEI-based regimens, Patient Level Prediction of Clinical Outcomes and Cost-Effectiveness in SPRINT (Optimize-SPRINT), Informing optimal first-line antihypertensive therapy: A rigorous comparative effectiveness analysis of ARBs vs. ACEIs on long-term risk of dementia, cancer, heart disease, and quality of life, Multidrug Metabolic Approach to Improve Exercise and Skeletal Muscle Oxidative Capacity in HFpEF, Targeting Skeletal Muscle Perfusion and Oxidative Capacity in HFpEF, Cardiovascular Risk, Vascular and Kidney Damage in COVID-19 Survivors, Continuation of the Chronic Renal Insufficiency Cohort (CRIC), Start Strong: A mixed methods study to inform initial antihypertensive prescribing and a patient-self titration intervention to improve blood pressure control, safety, and reduce cardiovascular risk, Using pharmacoepidemiology to optimize antihypertensive medication use to prevent aging-related multimorbidity: Midcareer investigator award in patient-oriented research and mentoring.

OpenAlex ID: W7167339713

FWCI:

Cites: 7

Cited by:

Related to: 10